Blood Tryptase Levels in People With Stable Coronary Artery Disease
Measures tryptase in blood to see how it relates to heart artery disease.
Plain-language title generated from the registry record
Registry title: Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
Key facts
- Where
- Athens and Larissa, GreeceSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06958016, who can take part
Where in Greece
- 417 Military Hospital NIMTSAthens, GreeceTaking people
- Larisa University HospitalLarissa, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Thessaly
- Trial code
- NCT06958016
- Record updated
- 28 May 2025
- Original description
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.Read full original descriptionShow less
Investigation of the Role and Prognostic Value of Tryptase in Patients With Stable Coronary Artery Disease
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.
Inclusion: Male and female subjects aged 18 - 85 years old; Clinical symptoms of angina which are classified based on the Canadian Cardiovascular Score (CCS score); Positive SPECT scan for myocardial ischemia.
Exclusion: Acute Coronary Syndrome 4 weeks before the coronary catheterization; Active symptoms of allergy (asthma, urticaria); Autoimmune disease; Cancer; Kidney failure; Myelodysplastic Syndrome; Percutaneous Coronary Angioplasty; Coronary Artery Bypass Graft; Mastocytosis; Hypereosinophilia; Denial of signing informed consent.